- 专利标题： PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF RIPK2
-
申请号： EP17768582.3申请日： 2017-09-06
-
公开(公告)号： EP3512837A1公开(公告)日： 2019-07-24
- 发明人: CUI, Jianwen , GAO, Donghong Amy , LIU, Pingrong , MCKIBBEN, Bryan Patrick , MILLER, Craig Andrew , RAZAVI, Hossein , RUPPEL, Sabine , PADYANA, Anil K. , SPENCER, Elizabeth
- 申请人： Boehringer Ingelheim International GmbH , Spencer, Elizabeth
- 申请人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 专利权人： Boehringer Ingelheim International GmbH,Spencer, Elizabeth
- 当前专利权人： Boehringer Ingelheim International GmbH,Spencer, Elizabeth
- 当前专利权人地址： Binger Strasse 173 55216 Ingelheim am Rhein DE
- 代理机构： Simon, Elke Anna Maria
- 优先权： US201662394780P 20160915
- 国际公布： WO2018052773 20180322
- 主分类号： C07D401/04
- IPC分类号： C07D401/04 ; C07D403/04 ; A61K31/4439 ; A61P29/00 ; A61P35/00 ; A61P37/06
摘要：
or pharmaceutically acceptable salts thereof, wherein R1, R2, X, Y, and HET are as defined herein. The invention also relates to pharmaceutical compositions comprising these compounds, methods of using these compounds in the treatment of various diseases and disorders, processes for preparing these compounds and intermediates useful in these processes
公开/授权文献
- EP3512837B1 PYRIDINE AND PYRAZINE COMPOUNDS AS INHIBITORS OF RIPK2 公开/授权日：2020-07-22
信息查询
